These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12042167)

  • 41. [The plasma homocysteine, folic acid and vitamin B12 levels in young people with high risk for cardiovascular disease and its relation to metylentetrahydrofolate reductase (MTHFR) gene polymorphism].
    Klujber V; Lengyel B; Szabó T; Németh A; Dobó M
    Orv Hetil; 2005 Apr; 146(14):649-51. PubMed ID: 15889539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study.
    Gjesdal CG; Vollset SE; Ueland PM; Refsum H; Drevon CA; Gjessing HK; Tell GS
    Arch Intern Med; 2006 Jan; 166(1):88-94. PubMed ID: 16401815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between MTHFR 677C-T polymorphism and alcohol dependence according to Lesch and Babor typology.
    Benyamina A; Saffroy R; Blecha L; Pham P; Karila L; Debuire B; Lemoine A; Reynaud M
    Addict Biol; 2009 Sep; 14(4):503-5. PubMed ID: 19650814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Lowering high levels of fasting total homocysteine with folic acid and vitamins B in patients with venous thromboembolism: relationship between response and the C677T methylenetetrahydrofolate reductase (MTHRF) genotype].
    González Ordóñez AJ; Medina Rodríguez JM; Fernández Alvarez CR; Sánchez García J; Fernández Carreira JM; Alvarez Martínez MV; Coto García E
    Med Clin (Barc); 2000 Jan; 114(1):7-12. PubMed ID: 10782453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of TCN2 776C>G on vitamin B12 cellular availability in end-stage renal disease patients.
    Födinger M; Veitl M; Skoupy S; Wojcik J; Röhrer C; Hagen W; Puttinger H; Hauser AC; Vychytil A; Sunder-Plassmann G
    Kidney Int; 2003 Sep; 64(3):1095-100. PubMed ID: 12911562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Diagnostic significance of mild hyperhomocysteinemia in a population of children with parents or grandparents who have peripheral or coronary artery disease].
    Hyánek J; Stríbrný J; Sebesta P; Klika M; Kramár J; Kozich V; Martiníková V; Machácková L; Orendác M; Loucka M; Dubská L; Pejznochová H; Táborský L; Cabrnochová I
    Cas Lek Cesk; 1999 May; 138(11):333-6. PubMed ID: 10422344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects.
    Gemmati D; Previati M; Serino ML; Moratelli S; Guerra S; Capitani S; Forini E; Ballerini G; Scapoli GL
    Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1761-7. PubMed ID: 10397696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The methylenetetrahydrofolate reductase polymorphism (MTHFR c.677C>T) and elevated plasma homocysteine levels in a U.S. pediatric population with incident thromboembolism.
    Joachim E; Goldenberg NA; Bernard TJ; Armstrong-Wells J; Stabler S; Manco-Johnson MJ
    Thromb Res; 2013 Aug; 132(2):170-4. PubMed ID: 23866722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism.
    Dragani A; Falco A; Santilli F; Basili S; Rolandi G; Cerasa L; Lattanzio S; Ciabattoni G; Patrono C; Davì G
    Thromb Haemost; 2012 Sep; 108(3):533-42. PubMed ID: 22782530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of folate supplementation on some coagulation parameters and oxidative status surrogates.
    Mayer O; Simon J; Rosolová H; Hromádka M; Subrt I; Vobrubová I
    Eur J Clin Pharmacol; 2002 Apr; 58(1):1-5. PubMed ID: 11956665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction between plasma homocysteine and the MTHFR c.677C > T polymorphism is associated with site-specific changes in DNA methylation in humans.
    Nash AJ; Mandaviya PR; Dib MJ; Uitterlinden AG; van Meurs J; Heil SG; Andrew T; Ahmadi KR
    FASEB J; 2019 Jan; 33(1):833-843. PubMed ID: 30080444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs.
    Belcastro V; Striano P; Gorgone G; Costa C; Ciampa C; Caccamo D; Pisani LR; Oteri G; Marciani MG; Aguglia U; Striano S; Ientile R; Calabresi P; Pisani F
    Epilepsia; 2010 Feb; 51(2):274-9. PubMed ID: 19780797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of methylenetetrahydrofolate reductase gene (MTHFR) 677C>T polymorphism in pediatric cerebrovascular disorders.
    Alsayouf H; Zamel KM; Heyer GL; Khuhro AL; Kahwash SB; de los Reyes EC
    J Child Neurol; 2011 Mar; 26(3):318-21. PubMed ID: 21270470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperhomocysteinemia, enzyme polymorphism and thiobarbituric Acid reactive system in children with high coronary risk family history.
    Szamosi T; Roth E; Szamosi T; Tomsits E; Tordai A; Szabo T
    J Am Coll Nutr; 2004 Oct; 23(5):386-90. PubMed ID: 15466944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Homocysteine, the methylenetetrahydrofolate reductase 677C>T polymorphism and hypertension: effect modifiers by lifestyle factors and population subgroups.
    Ornosa-Martín G; Fernandez-Ballart JD; Ceruelo S; Ríos L; Ueland PM; Meyer K; Murphy MM
    Br J Nutr; 2020 Jul; 124(1):69-79. PubMed ID: 32127061
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperhomocystinemia in children with inflammatory bowel disease.
    Nakano E; Taylor CJ; Chada L; McGaw J; Powers HJ
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):586-90. PubMed ID: 14581802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives.
    Tonstad S; Refsum H; Sivertsen M; Christophersen B; Ose L; Ueland PM
    Pediatr Res; 1996 Jul; 40(1):47-52. PubMed ID: 8798245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Polymorphism of the methylenetetrahydrofolate reductase gene (MTHFR) and incidence of hyperhomocysteinemia-related diseases].
    Pawlak AL; Strauss E
    Postepy Hig Med Dosw; 2001; 55(2):233-56. PubMed ID: 11468972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MTHFR 677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial.
    Fezeu LK; Ducros V; Guéant JL; Guilland JC; Andreeva VA; Hercberg S; Galan P
    PLoS One; 2018; 13(5):e0193352. PubMed ID: 29813097
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperhomocystinemia in patients with coronary artery disease.
    Faria-Neto JR; Chagas AC; Bydlowski SP; Lemos Neto PA; Chamone DA; Ramirez JA; da Luz PL
    Braz J Med Biol Res; 2006 Apr; 39(4):455-63. PubMed ID: 16612468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.